News

March 25, 2017, Cuu Long Pharmaceutical  JSC (DCL) held a groundbreaking ceremony to build capsules plant 3. The project has a total investment of 357 billion, divided to 3 phases,  and expected starting its operation from Q4/2017. Speaking at the ceremony, Mr. Nguyen Van Sang, Chairman and CEO of company said, this is an important […]

Cuu Long Pharmaceutical JSC (DCL) has announced it will contribute capital with State Capital Investment Corporation (SCIC) to the corporation of Benovas oncology JSC with an initial charter capital of 100 billion dong.After establishment, DCL owned 55% of charter capital.SCIC and other partners will hold the rest.     This is the first cancer drug […]

  25/02/2017, Cuu Long Pharmaceutical Joint Stock Company (DCL) held  2017 annual shareholders general meeting (SGM) in Hanoi. In this meeting, the SGM adopted the business plan in 2017 with net revenue at 914 billion and 96 billion profit after tax; up respectively 24% and 7% compared with 2016. According consolidated audited report in 2016, DCL […]

02.21.2017, FIT Group JSC (FIT code) has announced the registration of buying 3 million shares of Cuu Long Pharmaceutical JSC.Subscription period from of the transaction is expected from 24/02/2017 to 03/23/2017. With this plan, after completing of the purchase, FIT ownership will increase to 69.95 % charter capital instead of  64.62%  as current charter capital. […]